emerging glp-1 gip treatments 2025 Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research GLP-1s for Weight Loss: What

The medication is being prescribed for type 2 diabetes, moderate-to-severe obstructive sleep apnea or certain forms of MASH because those uses may need to be processed through your regular Medicare Part D plan

While nausea and vomiting are more common with short-acting agents, side effects such as itching or nodules at the injection site are more common with long-acting agents and usually disappear in 3 to 4 weeks

Research published in the European Journal of Endocrinology examined Ipamorelins effects on GH secretion and found that the peptide produced dose-dependent increases in GH levels without greatly affecting cortisol or prolactin

Improves Sleep Quality B12 has been linked to better sleep due to its role in melatonin production, the hormone responsible for regulating the sleep-wake cycle

CONTRAINDICATIONS None known

Efficacy in Different Populations The efficacy of GLP-1 versus GIP medications may vary among different populations